Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 9, no: 2 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0072546 | EMC complex | 3 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4HES3
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 11 |
GO:0030246 | carbohydrate binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 74 | 78 | PF00656 | 0.287 |
CLV_NRD_NRD_1 | 222 | 224 | PF00675 | 0.497 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.456 |
CLV_PCSK_PC1ET2_1 | 221 | 223 | PF00082 | 0.482 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.502 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.623 |
DOC_CYCLIN_yCln2_LP_2 | 168 | 174 | PF00134 | 0.385 |
DOC_MAPK_FxFP_2 | 99 | 102 | PF00069 | 0.301 |
DOC_MAPK_MEF2A_6 | 169 | 178 | PF00069 | 0.385 |
DOC_PP2B_LxvP_1 | 37 | 40 | PF13499 | 0.382 |
DOC_PP4_FxxP_1 | 70 | 73 | PF00568 | 0.337 |
DOC_PP4_FxxP_1 | 99 | 102 | PF00568 | 0.301 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.306 |
DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.309 |
DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.378 |
LIG_14-3-3_CanoR_1 | 211 | 217 | PF00244 | 0.554 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.537 |
LIG_14-3-3_CterR_2 | 222 | 227 | PF00244 | 0.596 |
LIG_Actin_WH2_2 | 179 | 197 | PF00022 | 0.496 |
LIG_APCC_ABBA_1 | 186 | 191 | PF00400 | 0.671 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.145 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.228 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.337 |
LIG_FHA_2 | 72 | 78 | PF00498 | 0.287 |
LIG_HP1_1 | 171 | 175 | PF01393 | 0.475 |
LIG_IRF3_LxIS_1 | 173 | 179 | PF10401 | 0.390 |
LIG_LIR_Apic_2 | 154 | 158 | PF02991 | 0.280 |
LIG_LIR_Apic_2 | 81 | 86 | PF02991 | 0.358 |
LIG_LIR_Apic_2 | 98 | 102 | PF02991 | 0.297 |
LIG_LIR_Gen_1 | 48 | 58 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 95 | 104 | PF02991 | 0.281 |
LIG_LIR_Nem_3 | 150 | 155 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 32 | 37 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 48 | 53 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 77 | 83 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 95 | 99 | PF02991 | 0.277 |
LIG_NRBOX | 163 | 169 | PF00104 | 0.200 |
LIG_NRBOX | 181 | 187 | PF00104 | 0.153 |
LIG_PCNA_yPIPBox_3 | 159 | 168 | PF02747 | 0.317 |
LIG_SH2_CRK | 34 | 38 | PF00017 | 0.349 |
LIG_SH2_CRK | 83 | 87 | PF00017 | 0.326 |
LIG_SH2_STAT3 | 64 | 67 | PF00017 | 0.353 |
LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.277 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.302 |
LIG_SUMO_SIM_anti_2 | 163 | 170 | PF11976 | 0.381 |
LIG_SUMO_SIM_par_1 | 174 | 179 | PF11976 | 0.388 |
LIG_SUMO_SIM_par_1 | 20 | 25 | PF11976 | 0.574 |
LIG_TRAF2_1 | 190 | 193 | PF00917 | 0.664 |
LIG_TRAF2_1 | 26 | 29 | PF00917 | 0.545 |
LIG_TRAF2_2 | 158 | 163 | PF00917 | 0.381 |
LIG_UBA3_1 | 181 | 187 | PF00899 | 0.410 |
LIG_WW_1 | 40 | 43 | PF00397 | 0.449 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.589 |
MOD_GlcNHglycan | 112 | 116 | PF01048 | 0.473 |
MOD_GlcNHglycan | 135 | 139 | PF01048 | 0.541 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.485 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.474 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.678 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.358 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.311 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.683 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.325 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.250 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.320 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.600 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.602 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.567 |
MOD_NEK2_2 | 78 | 83 | PF00069 | 0.358 |
MOD_PIKK_1 | 194 | 200 | PF00454 | 0.673 |
MOD_PKA_1 | 221 | 227 | PF00069 | 0.715 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.344 |
MOD_PKA_2 | 194 | 200 | PF00069 | 0.685 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.601 |
MOD_PKA_2 | 210 | 216 | PF00069 | 0.493 |
MOD_PKA_2 | 221 | 227 | PF00069 | 0.633 |
MOD_Plk_1 | 27 | 33 | PF00069 | 0.284 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.304 |
MOD_Plk_4 | 163 | 169 | PF00069 | 0.295 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.381 |
MOD_Plk_4 | 57 | 63 | PF00069 | 0.308 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.305 |
MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.309 |
MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.378 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.290 |
TRG_Pf-PMV_PEXEL_1 | 123 | 128 | PF00026 | 0.497 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCU9 | Leptomonas seymouri | 68% | 99% |
A0A0S4JJC6 | Bodo saltans | 31% | 91% |
A0A1X0NSE7 | Trypanosomatidae | 43% | 91% |
A0A3Q8IDJ8 | Leishmania donovani | 78% | 100% |
A0A422N2I9 | Trypanosoma rangeli | 38% | 97% |
A4I200 | Leishmania infantum | 78% | 100% |
C9ZS15 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 94% |
E9AY47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4Q9C6 | Leishmania major | 77% | 100% |
V5DR28 | Trypanosoma cruzi | 41% | 100% |